Trial NCT00226941

View at ClinicalTrials.gov 
Org. Study IDs: IRB-12426
Secondary IDs: 95054 COR0001

Last trial update was posted on 2017-12-08

MeSH Interventions

Capecitabine Cetuximab Diphenhydramine Oxaliplatin Promethazine

MeSH Conditions

Rectal Neoplasms

Other Conditions

Colo-rectal Cancer Rectal Cancer

Stopping Reasons

The response rate observed in the phase 1 portion of the study did not merit further evaluation in phase 2 portion of the study.

Limitations And Caveats

This trial was halted after the phase 1 portion of enrollment, and before the phase 2 portion accrued. Data reported for phase 2 objectives/outcomes do not include any phase 2 participants, and are only provided for completeness.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID